Pancreatic Cancer Research

ResearcherNorth Dakota State UniversityActive in the last 2 years

Yongki Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8890-8344; OpenAlex author ID A5090597061; NIH RePORTER profile ID 11466848. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
31
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers, 1 grant

Papers 10

  1. Nanoparticles for Delivery of Encapsulated Drugs to Hypoxic Pancreatic Ductal Adenocarcinoma Cell Spheroids. Co-author DOI 10.1021/acs.molpharmaceut.5c01395↗
  2. Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy. Co-author DOI 10.3390/biom16020269↗
  3. Differential extracellular vesicle concentration and their biomarker expression of integrin αv/β5, EpCAM, and glypican-1 in pancreatic cancer models. Last author DOI 10.1038/s41598-024-65209-8↗
  4. Single-Molecule Force Probing of RGD-Binding Integrins on Pancreatic Cancer Cells. Last author DOI 10.1021/acsami.1c23361↗
  5. Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14102448↗
  6. Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.8b01133↗
  7. Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors. Co-author DOI 10.1021/acs.molpharmaceut.7b00014↗
  8. Acridine Orange Conjugated Polymersomes for Simultaneous Nuclear Delivery of Gemcitabine and Doxorubicin to Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.bioconjchem.5b00694↗
  9. Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids. Co-author DOI 10.1021/acs.bioconjchem.6b00241↗
  10. Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.6b00350↗

Grants 1

  1. Biostatistics and Bioinformatics Core Facility P20GM109024↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sanku Mallik · 7 shared papers, 1 shared grant, 2016–2026 · strength 1.24
  2. Jiha Kim · 3 shared papers, 1 shared grant, 2022–2026 · strength 1.02
  3. Buddhadev Layek · 1 shared paper, 1 shared grant, 2026 · strength 0.82
  4. Reed I. Jacobson · 3 shared papers, 2022–2024 · strength 0.56
  5. Sathish Venkatachalem · 1 shared grant, 2026 · strength 0.46
  6. Megan Orr · 1 shared grant, 2026 · strength 0.46
  7. Mohiuddin Quadir · 1 shared grant, 2026 · strength 0.46
  8. Ang Guo · 1 shared grant, 2026 · strength 0.46
  9. Mark T Hamann · 1 shared grant, 2026 · strength 0.46
  10. Roberto Gomes · 1 shared grant, 2026 · strength 0.46
  11. Jagdish Singh · 1 shared grant, 2026 · strength 0.46
  12. Estelle Leclerc · 1 shared grant, 2026 · strength 0.46
  13. John Curlee Wilkinson · 1 shared grant, 2026 · strength 0.46
  14. Elisabetta Liverani · 1 shared grant, 2026 · strength 0.46
  15. Erxi Wu · 1 shared grant, 2026 · strength 0.46
  16. Bin Guo · 1 shared grant, 2026 · strength 0.46
  17. Katie M. Reindl · 1 shared grant, 2026 · strength 0.46
  18. Guodong Liu · 1 shared grant, 2026 · strength 0.46
  19. Rick J. Jansen · 1 shared grant, 2026 · strength 0.46
  20. Anurag Banerjee · 1 shared paper, 2026 · strength 0.36
  21. Paras Mani Giri · 1 shared paper, 2026 · strength 0.36
  22. Lina Alhalhooly · 2 shared papers, 2022 · strength 0.33
  23. Chukwuebuka Ozoude · 1 shared paper, 2026 · strength 0.28
  24. Randall E. Brand · 1 shared paper, 2024 · strength 0.23
  25. Vikneshwari Natarajan · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.